Literature DB >> 603311

Noradrenergic mediation of the positive reinforcing properties of ethanol: II. Extinction of ethanol-drinking behavior in laboratory rats by inhibition of dopamine-beta-hydroxylase. Implications for treatment procedures in human alcoholics.

Z W Brown, Z Amit, D E Levitan, S O Ogren, E A Sutherland.   

Abstract

Following stabilization of consumption of a 15% (v/v) ethanol solution in a free-choice with water, rats were presented with a forced-choice of ethanol for 10 consecutive alternate days. Prior to each forced-choice presentation experimental animals were injected with the non-toxic dopamine-beta-hydroxylase inhibitor FLA-57 (30 mg/kg i.p.) while control animals received only vehicle injections. At the termination of the injection phase when ethanol was again made available in a free-choice with water, ethanol consumption for the FLA-57 treated animals was markedly suppressed. These data are interpreted in terms of extinction resulting from the procedure whereby performance of the ethanol drinking response was perpetuated by force with the pharmacological reinforcing properties being blocked by FLA-57-induced depletions of norepinephrine. Applications of these procedures in the treatment of human alcoholics are discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 603311

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


  13 in total

1.  Effects of β-adrenoceptor antagonists on alcohol drinking by alcohol-dependent rats.

Authors:  Nicholas W Gilpin; George F Koob
Journal:  Psychopharmacology (Berl)       Date:  2010-07-31       Impact factor: 4.530

2.  Ethanol-associated behaviors of mice lacking norepinephrine.

Authors:  D Weinshenker; N C Rust; N S Miller; R D Palmiter
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

3.  Regional brain [Met]-enkephalin in alcohol-preferring and non-alcohol-preferring inbred strains of mice.

Authors:  K Blum; A H Briggs; J E Wallace; C W Hall; M A Trachtenberg
Journal:  Experientia       Date:  1987-04-15

Review 4.  Impact of gender on corticotropin-releasing factor and noradrenergic sensitivity in cocaine use disorder.

Authors:  Aimee L McRae-Clark; Angie M Cason; Amy S Kohtz; Megan Moran Santa-Maria; Gary Aston-Jones; Kathleen T Brady
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

5.  Central Noradrenergic Interactions with Alcohol and Regulation of Alcohol-Related Behaviors.

Authors:  Elena M Vazey; Carolina R den Hartog; David E Moorman
Journal:  Handb Exp Pharmacol       Date:  2018

Review 6.  Targeting the noradrenergic system for gender-sensitive medication development for tobacco dependence.

Authors:  Terril L Verplaetse; Andrea H Weinberger; Philip H Smith; Kelly P Cosgrove; Yann S Mineur; Marina R Picciotto; Carolyn M Mazure; Sherry A McKee
Journal:  Nicotine Tob Res       Date:  2015-03-11       Impact factor: 4.244

7.  alpha1-noradrenergic receptor antagonism blocks dependence-induced increases in responding for ethanol.

Authors:  Brendan M Walker; Dennis D Rasmussen; Murray A Raskind; George F Koob
Journal:  Alcohol       Date:  2008-03       Impact factor: 2.405

8.  The α2-adrenergic receptor agonist, clonidine, reduces alcohol drinking in alcohol-preferring (P) rats.

Authors:  Dennis D Rasmussen; Laura Alexander; Julia Malone; David Federoff; Janice C Froehlich
Journal:  Alcohol       Date:  2014-07-14       Impact factor: 2.405

Review 9.  Norepinephrine at the nexus of arousal, motivation and relapse.

Authors:  Rodrigo A España; Brooke E Schmeichel; Craig W Berridge
Journal:  Brain Res       Date:  2016-01-07       Impact factor: 3.252

10.  The alpha1-adrenergic receptor antagonist, prazosin, reduces alcohol drinking in alcohol-preferring (P) rats.

Authors:  Dennis D Rasmussen; Laura L Alexander; Murray A Raskind; Janice C Froehlich
Journal:  Alcohol Clin Exp Res       Date:  2008-11-19       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.